The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Timothy E. Wilens

Massachusetts General Hospital

Boston

USA

[email]@partners.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Massachusetts General Hospital, Boston, USA. 2008 - 2012
  • Massachusetts General Hospital, Pediatric Psychopharmacology Unit, 55 Fruit Street, Boston, USA. 2005 - 2011
  • Clinical and Research Program in Pediatric Psychopharmacology, PediatricPsychopharmacology Unit, Massachusetts General Hospital, 55 Parkman Street., USA. 2011
  • Pediatric Psychopharmacology Unit, Massachusetts General Hospital, YAW 6A, 55 Fruit Street, USA. 2003 - 2009
  • Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA. 2004 - 2006

References

  1. A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder. Wilens, T.E., Bukstein, O., Brams, M., Cutler, A.J., Childress, A., Rugino, T., Lyne, A., Grannis, K., Youcha, S. J. Am. Acad. Child. Adolesc. Psychiatry (2012) [Pubmed]
  2. Safety and efficacy of ABT-089 in pediatric attention-deficit/hyperactivity disorder: results from two randomized placebo-controlled clinical trials. Wilens, T.E., Gault, L.M., Childress, A., Kratochvil, C.J., Bensman, L., Hall, C.M., Olson, E., Robieson, W.Z., Garimella, T.S., Abi-Saab, W.M., Apostol, G., Saltarelli, M.D. J. Am. Acad. Child. Adolesc. Psychiatry (2011) [Pubmed]
  3. Do executive function deficits predict later substance use disorders among adolescents and young adults? Wilens, T.E., Martelon, M., Fried, R., Petty, C., Bateman, C., Biederman, J. J. Am. Acad. Child. Adolesc. Psychiatry (2011) [Pubmed]
  4. A controlled trial of the methylphenidate transdermal system on before-school functioning in children with attention-deficit/hyperactivity disorder. Wilens, T.E., Hammerness, P., Martelon, M., Brodziak, K., Utzinger, L., Wong, P. J. Clin. Psychiatry (2010) [Pubmed]
  5. Presenting ADHD symptoms, subtypes, and comorbid disorders in clinically referred adults with ADHD. Wilens, T.E., Biederman, J., Faraone, S.V., Martelon, M., Westerberg, D., Spencer, T.J. J. Clin. Psychiatry (2009) [Pubmed]
  6. Does conduct disorder mediate the development of substance use disorders in adolescents with bipolar disorder? A case-control family study. Wilens, T.E., Martelon, M., Kruesi, M.J., Parcell, T., Westerberg, D., Schillinger, M., Gignac, M., Biederman, J. J. Clin. Psychiatry (2009) [Pubmed]
  7. An open study of adjunct OROS-methylphenidate in children and adolescents who are atomoxetine partial responders: I. Effectiveness. Wilens, T.E., Hammerness, P., Utzinger, L., Schillinger, M., Georgiopoulous, A., Doyle, R.L., Martelon, M., Brodziak, K. J. Child. Adolesc. Psychopharmacol (2009) [Pubmed]
  8. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. Wilens, T.E. J. Clin. Psychopharmacol (2008) [Pubmed]
  9. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Wilens, T.E., Adamson, J., Monuteaux, M.C., Faraone, S.V., Schillinger, M., Westerberg, D., Biederman, J. Arch. Pediatr. Adolesc. Med (2008) [Pubmed]
  10. A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD. Wilens, T.E., Klint, T., Adler, L., West, S., Wesnes, K., Graff, O., Mikkelsen, B. Behav. Brain. Funct (2008) [Pubmed]
  11. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Wilens, T.E., Adler, L.A., Weiss, M.D., Michelson, D., Ramsey, J.L., Moore, R.J., Renard, D., Brady, K.T., Trzepacz, P.T., Schuh, L.M., Ahrbecker, L.M., Levine, L.R. Drug. Alcohol. Depend (2008) [Pubmed]
  12. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. Wilens, T.E., Adler, L.A., Adams, J., Sgambati, S., Rotrosen, J., Sawtelle, R., Utzinger, L., Fusillo, S. J. Am. Acad. Child. Adolesc. Psychiatry (2008) [Pubmed]
  13. Further evidence of an association between adolescent bipolar disorder with smoking and substance use disorders: a controlled study. Wilens, T.E., Biederman, J., Adamson, J.J., Henin, A., Sgambati, S., Gignac, M., Sawtelle, R., Santry, A., Monuteaux, M.C. Drug. Alcohol. Depend (2008) [Pubmed]
  14. Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder. Wilens, T.E., Boellner, S.W., López, F.A., Turnbow, J.M., Wigal, S.B., Childress, A.C., Abikoff, H.B., Manos, M.J. J. Am. Acad. Child. Adolesc. Psychiatry (2008) [Pubmed]
  15. Concordance between cigarette smoking and the modified Fagerström Tolerance Questionnaire in controlled studies of ADHD. Wilens, T.E., Vitulano, M., Upadhyaya, H., Adamson, J., Parcell, T., Westerberg, D., Biederman, J. Am. J. Addict (2008) [Pubmed]
  16. Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition. Wilens, T.E., Decker, M.W. Biochem. Pharmacol. (2007) [Pubmed]
  17. Do individuals with ADHD self-medicate with cigarettes and substances of abuse? Results from a controlled family study of ADHD. Wilens, T.E., Adamson, J., Sgambati, S., Whitley, J., Santry, A., Monuteaux, M.C., Biederman, J. Am. J. Addict (2007) [Pubmed]
  18. Association of bipolar and substance use disorders in parents of adolescents with bipolar disorder. Wilens, T.E., Biederman, J., Adamson, J., Monuteaux, M., Henin, A., Sgambati, S., Santry, A., Faraone, S.V. Biol. Psychiatry (2007) [Pubmed]
  19. When ADHD and substance use disorders intersect: relationship and treatment implications. Wilens, T.E., Fusillo, S. Curr. Psychiatry. Rep (2007) [Pubmed]
  20. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use. Wilens, T.E. J. Clin. Psychiatry (2007) [Pubmed]
  21. Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth. Wilens, T.E., Biederman, J. J. Psychopharmacol. (Oxford) (2006) [Pubmed]
  22. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder. Wilens, T.E., McBurnett, K., Bukstein, O., McGough, J., Greenhill, L., Lerner, M., Stein, M.A., Conners, C.K., Duby, J., Newcorn, J., Bailey, C.E., Kratochvil, C.J., Coury, D., Casat, C., Denisco, M.J., Halstead, P., Bloom, L., Zimmerman, B.A., Gu, J., Cooper, K.M., Lynch, J.M. Arch. Pediatr. Adolesc. Med (2006) [Pubmed]
  23. Do children and adolescents with ADHD respond differently to atomoxetine?. Wilens, T.E., Kratochvil, C., Newcorn, J.H., Gao, H. J. Am. Acad. Child. Adolesc. Psychiatry (2006) [Pubmed]
  24. ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study. Wilens, T.E., Verlinden, M.H., Adler, L.A., Wozniak, P.J., West, S.A. Biol. Psychiatry (2006) [Pubmed]
  25. Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. Wilens, T.E., Gignac, M., Swezey, A., Monuteaux, M.C., Biederman, J. J. Am. Acad. Child. Adolesc. Psychiatry (2006) [Pubmed]
  26. An open-label study of the tolerability of mixed amphetamine salts in adults with attention-deficit/hyperactivity disorder and treated primary essential hypertension. Wilens, T.E., Zusman, R.M., Hammerness, P.G., Podolski, A., Whitley, J., Spencer, T.J., Gignac, M., Biederman, J. J. Clin. Psychiatry (2006) [Pubmed]
  27. Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder. Wilens, T.E., Newcorn, J.H., Kratochvil, C.J., Gao, H., Thomason, C.K., Rogers, A.K., Feldman, P.D., Levine, L.R. J. Pediatr. (2006) [Pubmed]
  28. Stimulants and sudden death: what is a physician to do?. Wilens, T.E., Prince, J.B., Spencer, T.J., Biederman, J. Pediatrics (2006) [Pubmed]
  29. Mechanism of action of agents used in attention-deficit/hyperactivity disorder. Wilens, T.E. J. Clin. Psychiatry (2006) [Pubmed]
  30. Attention deficit hyperactivity disorder and substance use disorders. Wilens, T.E. Am. J. Psychiatry (2006) [Pubmed]
  31. Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder. Wilens, T.E., Hammerness, P.G., Biederman, J., Kwon, A., Spencer, T.J., Clark, S., Scott, M., Podolski, A., Ditterline, J.W., Morris, M.C., Moore, H. J. Clin. Psychiatry (2005) [Pubmed]
  32. Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Wilens, T.E., Haight, B.R., Horrigan, J.P., Hudziak, J.J., Rosenthal, N.E., Connor, D.F., Hampton, K.D., Richard, N.E., Modell, J.G. Biol. Psychiatry (2005) [Pubmed]
  33. Influence of parental SUD and ADHD on ADHD in their offspring: preliminary results from a pilot-controlled family study. Wilens, T.E., Hahesy, A.L., Biederman, J., Bredin, E., Tanguay, S., Kwon, A., Faraone, S.V. Am. J. Addict (2005) [Pubmed]
  34. ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study. Wilens, T., McBurnett, K., Stein, M., Lerner, M., Spencer, T., Wolraich, M. J. Am. Acad. Child. Adolesc. Psychiatry (2005) [Pubmed]
  35. Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity. Wilens, T.E., Kwon, A., Tanguay, S., Chase, R., Moore, H., Faraone, S.V., Biederman, J. Am. J. Addict (2005) [Pubmed]
  36. The clinical dilemma of using medications in substance-abusing adolescents and adults with attention-deficit/hyperactivity disorder: what does the literature tell us?. Wilens, T.E., Monuteaux, M.C., Snyder, L.E., Moore, H., Whitley, J., Gignac, M. J. Child. Adolesc. Psychopharmacol (2005) [Pubmed]
  37. An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder. Wilens, T.E., Waxmonsky, J., Scott, M., Swezey, A., Kwon, A., Spencer, T.J., Biederman, J. J. Child. Adolesc. Psychopharmacol (2005) [Pubmed]
  38. Impact of ADHD and its treatment on substance abuse in adults. Wilens, T.E. J. Clin. Psychiatry (2004) [Pubmed]
  39. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Wilens, T.E. Psychiatr. Clin. North Am. (2004) [Pubmed]
  40. Attention-deficit/hyperactivity disorder in adults. Wilens, T.E., Faraone, S.V., Biederman, J. JAMA (2004) [Pubmed]
  41. A clinical perspective of attention-deficit/hyperactivity disorder into adulthood. Wilens, T.E., Dodson, W. J. Clin. Psychiatry (2004) [Pubmed]
  42. Risk of substance use disorders in adolescents with bipolar disorder. Wilens, T.E., Biederman, J., Kwon, A., Ditterline, J., Forkner, P., Moore, H., Swezey, A., Snyder, L., Henin, A., Wozniak, J., Faraone, S.V. J. Am. Acad. Child. Adolesc. Psychiatry (2004) [Pubmed]
  43. Patterns of comorbidity and dysfunction in clinically referred preschool and school-age children with bipolar disorder. Wilens, T.E., Biederman, J., Forkner, P., Ditterline, J., Morris, M., Moore, H., Galdo, M., Spencer, T.J., Wozniak, J. J. Child. Adolesc. Psychopharmacol (2003) [Pubmed]
 
WikiGenes - Universities